Chemicals giant DSM has partnered with Panaceutics, which makes personalized nutritional gels and purees to compete against the personalized packs of pills that dominate supplement subscription services.
By Michael McGuffin, president, American Herbal Products Association
Looking back 25 years, there are several remarkable aspects of the Dietary Supplement Health and Education Act (DSHEA) amendments to the Food Drug and Cosmetic Act (FD&C Act), which transformed how dietary supplements are regulated.
Neptune Wellness Solutions has completed a radical refocus of the company with the announcement of its entry into the hemp/CBD market in the United States.
The US Food and Drug Administration issued 11 warning letters yesterday to companies that have non NDI ingredients in their products. Eight of the warning letters concerned DMHA, with the other three concerned phenibut.
NutraIngredients-USA is on the hunt for entrepreneurial consumer-facing, science- or technology-based start-ups to join our Probiota Pioneers session and present their company in Vancouver.
Researchers in Poland argued that most studies on crickets’ nutritive values were done on lab-grown varieties, so they sought out the nutrition content of commercially available cricket powders.
The recent slew of crackdowns, regulatory reviews and stricter rules for China's health food and supplement industry are 'growing pains' the industry must overcome, as regulators double down on efforts to promote safety and collect taxes.
Chilean omega-3 concentrates manufacturer Golden Omega has acquired OmegaTri AS, the Norwegian developer of an innovative omega-3 compressible powder technology.
Setting firm commodity prices will be one brick in the wall of a fully legitimized hemp industry. One company has set about doing so with a proprietary trading platform.
Wastage minimisation, standardisation of herbal extracts, and catering to niche market segments are vital to longevity in APAC's nutraceutical market, according to a long-standing R&D expert.
New studies using palmitoylethanolamide, an endocannabinoid-like molecule with potent anti-inflammatory properties, may offer formulators possibilities for new joint health and sports recovery products, and an alternative to CBD.
